• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一家主要转诊中心对620例恶性黑色素瘤患者进行的长期分析。

A long-term analysis of 620 patients with malignant melanoma at a major referral center.

作者信息

Averbook B J, Russo L J, Mansour E G

机构信息

Department of Surgery, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio 44109-1998, USA.

出版信息

Surgery. 1998 Oct;124(4):746-55; discussion 755-6. doi: 10.1067/msy.1998.91269.

DOI:10.1067/msy.1998.91269
PMID:9780997
Abstract

BACKGROUND

A univariate and multivariate statistical analysis of a single surgeon's experience with resectable malignant melanoma during 26 years (November 1970 to August 1996) was conducted.

METHODS

Six hundred twenty consecutive patients were registered. Univariate analysis of disease-free survival (DFS) and melanoma survival (MS) was calculated by the Kaplan-Meier method and correlated to American Joint Committee on Cancer stage, thickness, ulceration, site, lymph node involvement, age, sex, type, and excision margins. Linear trends, log-rank test, and pairwise comparisons were used to discriminate differences in survival curves. A Cox proportional hazards model was used for multivariate analysis and determination of relative risk.

RESULTS

Univariate analysis of stage, thickness (in millimeters), ulceration, lymph node involvement, age, type, and margins of excision were predictive of DFS (5 years, 85.7%; 10 years, 82.5%) and MS (5 years, 92.2%; 10 years, 87.8%) (P < .01). Multivariate analysis revealed correlations with thickness, ulceration, and age in predicting DFS (relative risk = 2.75, 2.21, and 1.47, respectively) and MS (relative risk = 2.66, 2.47, and 1.48, respectively). The 5-year MS rate was 73.3% and 93.3% for patients with positive and negative lymph nodes, respectively. Of 133 patients who underwent lymph node dissection, 28 (21.1%) had nodal metastases. Patients with primary melanomas thicker than 4 mm had 50% metastatic involvement of their lymph nodes.

CONCLUSIONS

Our findings reveal that thickness, ulceration, and age are the most important predicting factors in DFS and MS. The data support including ulceration and age in modifying American Joint Committee on Cancer staging for melanoma.

摘要

背景

对一位外科医生在26年(1970年11月至1996年8月)期间治疗可切除恶性黑色素瘤的经验进行了单因素和多因素统计分析。

方法

连续登记了620例患者。采用Kaplan-Meier法计算无病生存期(DFS)和黑色素瘤生存期(MS)的单因素分析,并与美国癌症联合委员会分期、厚度、溃疡、部位、淋巴结受累情况、年龄、性别、类型和切缘相关。使用线性趋势、对数秩检验和两两比较来区分生存曲线的差异。采用Cox比例风险模型进行多因素分析并确定相对风险。

结果

对分期、厚度(以毫米为单位)、溃疡、淋巴结受累情况、年龄、类型和切缘的单因素分析可预测DFS(5年,85.7%;10年,82.5%)和MS(5年,92.2%;10年,87.8%)(P <.01)。多因素分析显示,在预测DFS(相对风险分别为2.75、2.21和1.47)和MS(相对风险分别为2.66、2.47和1.48)方面,与厚度、溃疡和年龄相关。淋巴结阳性和阴性患者的5年MS率分别为73.3%和93.3%。在133例行淋巴结清扫术的患者中,28例(21.1%)有淋巴结转移。原发性黑色素瘤厚度超过4mm的患者,其淋巴结转移率为50%。

结论

我们的研究结果表明,厚度、溃疡和年龄是DFS和MS最重要的预测因素。这些数据支持在修订美国癌症联合委员会黑色素瘤分期时纳入溃疡和年龄因素。

相似文献

1
A long-term analysis of 620 patients with malignant melanoma at a major referral center.在一家主要转诊中心对620例恶性黑色素瘤患者进行的长期分析。
Surgery. 1998 Oct;124(4):746-55; discussion 755-6. doi: 10.1067/msy.1998.91269.
2
Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.前哨淋巴结微转移及其他组织学因素对较厚黑色素瘤患者预后的预测作用
J Am Acad Dermatol. 2001 May;44(5):762-6. doi: 10.1067/mjd.2001.112346.
3
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.前哨淋巴结状态是预测Ⅰ期或Ⅱ期皮肤黑色素瘤患者临床结局的重要因素。
Cancer. 2001 Jun 15;91(12):2401-8.
4
Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.在多变量分析中,黑色素瘤患者的前哨淋巴结状态对总生存期并无预测作用。
Br J Cancer. 2005 Feb 28;92(4):662-7. doi: 10.1038/sj.bjc.6602391.
5
Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.盆腔淋巴结清扫术对淋巴结阳性黑色素瘤患者的某些亚组有益。
Ann Surg Oncol. 2007 Oct;14(10):2867-75. doi: 10.1245/s10434-007-9512-7. Epub 2007 Aug 1.
6
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.溃疡作为预测黑色素瘤辅助干扰素治疗反应的标志物。
Ann Surg. 2010 Sep;252(3):460-5; discussion 465-6. doi: 10.1097/SLA.0b013e3181f20bb1.
7
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.预测美国癌症联合委员会(AJCC)临床I-II期皮肤黑色素瘤前哨淋巴结阳性、无病生存期和总生存期的临床及组织病理学危险因素:来自单机构前瞻性收集数据库的结果分析
Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.
8
Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.773例前哨淋巴结肿瘤阴性的黑色素瘤患者的自然病史。
Ann Surg Oncol. 2007 May;14(5):1604-11. doi: 10.1245/s10434-006-9267-6. Epub 2007 Mar 1.
9
Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.III期黑色素瘤的分子和生化检测:淋巴结清扫术后淋巴液的多标志物逆转录聚合酶链反应检测及术前血清乳酸脱氢酶水平
Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.
10
A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.一项回顾性观察研究,比较仅接受切除术治疗的原发性皮肤恶性黑色素瘤患者与先行切除活检再行更广泛局部切除的患者。
Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x.

引用本文的文献

1
Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.转移性黑色素瘤的新型疗法:老年患者使用情况的最新进展
Drugs Aging. 2015 Oct;32(10):821-34. doi: 10.1007/s40266-015-0304-7.
2
Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.黑色素瘤区域淋巴结转移的检测;老年患者与年轻患者在检测方面的差异不影响生存率。
Ann Surg Oncol. 2010 Nov;17(11):3008-14. doi: 10.1245/s10434-010-1085-1. Epub 2010 May 5.